Tower Research Capital (TRC)’s Fidelity Disruptive Medicine ETF FMED Stock Holding History
Bought
Maintained
Sold
Other funds holding FMED
BP
Tower Research Capital (TRC)'s FMED Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Fidelity Disruptive Medicine ETF (FMED) in Q3 2026: 65 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #5137 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in FMED as recently as Q4 2024.
Tower Research Capital (TRC) first reported a position in FMED in Q3 2023 and has held it in 7 quarters since. The position peaked at $4.26K in Q3 2024. 14 funds tracked by Wall St. Rank hold FMED as of Q3 2026.
- Tower Research Capital (TRC) held 65 shares of Fidelity Disruptive Medicine ETF worth $2.1K as of Q3 2026.
- Fidelity Disruptive Medicine ETF was a new Tower Research Capital (TRC) position in Q3 2026.
- Fidelity Disruptive Medicine ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5137 holding.
- Tower Research Capital (TRC) first reported a position in Fidelity Disruptive Medicine ETF in Q3 2023 and has held it in 7 quarters since.
- Tower Research Capital (TRC)'s Fidelity Disruptive Medicine ETF position peaked at $4.26K in Q3 2024.
- 14 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.